New antibody drug tested in healthy volunteers for first time
NCT ID NCT07439263
First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This early-stage study tests a new drug called HB2198 in 32 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose of the drug or a placebo and are monitored for about two months. The study focuses on safety and drug levels in the blood, not on treating any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Veritus Research
RECRUITINGBayswater, Victoria, 3153, Australia
Conditions
Explore the condition pages connected to this study.